Clinical Trial Update: Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports the completed Phase 3 evaluation of GreenGene recombinant Factor VIII in patients with Hemophilia A, focusing on efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• GreenGene Recombinant Factor VIII (recombinant factor VIII)

Snippet

Sponsor: Green Cross Corporation | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED